Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.
Abstract:
Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
The invention provides a method of amplification of DNA coding for a cellular protein such as a cell surface receptor wherein host eukaryotic cells transfected with DNA fragments comprising a DNA eukaryotic library, including DNA coding for said cellular protein, inserted in an expression vector capable of expression in the host eukaryotic cells, is contacted with a ligand specific to said cellular protein, the ligand being labelled before or after such contact, whereby individual host eukaryotic cells expressing the protein are identified and selected, the vector DNA then being subjected to cloning or other amplification, optionally after being extracted from said eukaryotic cells.
Abstract:
A poliovirus which is either a type 3 poliovirus having amino acid residues valine and alanine at positions 54 and 114 respectively of the VP1 capsid protein or is a type 1 or type 2 poliovirus having equivalent amino acid residues at corresponding positions.
Abstract:
A method and system for notifying one or more non-emergency vehicle computing devices of an emergency event includes processing information about the emergency event received from an emergency vehicle computing device, comparing the location of the emergency vehicle to the location of the non-emergency vehicle, and sending a notification of the emergency event to the non-emergency vehicle computing devices based on the comparison.
Abstract:
A method is disclosed. The method includes simulating a preprinted form using a presentation overlay. The presentation device is directed to present the overlay as if it had been preprinted on the paper. Document data is then mixed with the simulated preprinted form such that the result accurately simulates a real preprinted form.
Abstract:
A fiber panel system includes a chassis and at least blades configured to mount to the chassis. Each blade is moveable relative to the chassis between a retracted (closed) position and at least one extended position. Cable slack is managed at the front and/or rear of each chassis to facilitate movement of the blades without pulling or bending the cables beyond a maximum bend limit. Each blade may be locked into one or more positions relative to the chassis.